Showing results (21-30 of 28) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
The Journal of Antimicrobial Chemotherapy|August 28, 2021
High-level resistance to bictegravir and cabotegravir in subtype A- and D-infected HIV-1 patients failing raltegravir with multiple resistance mutationsEmmanuel Ndashimye, Yue Li, Paul S Reyes, et al.Cells|September 28, 2021
Interferon-Induced HERC5 Inhibits Ebola Virus Particle Production and Is Antagonized by Ebola GlycoproteinErmela Paparisto, Nina R Hunt, Daniel S Labach, et al.Iscience|March 14, 2023
Monovalent and trivalent VSV-based COVID-19 vaccines elicit neutralizing antibodies and CD8<sup>+</sup> T cells against SARS-CoV-2 variantsKate A Parham, Gyoung Nyoun Kim, Connor G Richer, et al.Communications Medicine|October 6, 2025
Early pandemic HIV-1 integration site preferences differ across anatomical sitesHinissan P Kohio, Hannah O Ajoge, Emile A Barua, et al.Journal of Virology|April 20, 2018
Evolution-Guided Structural and Functional Analyses of the HERC Family Reveal an Ancient Marine Origin and Determinants of Antiviral ActivityErmela Paparisto, Matthew W Woods, Macon D Coleman, et al.Plos Pathogens|June 29, 2023
Targeting the MR1-MAIT cell axis improves vaccine efficacy and affords protection against viral pathogensRasheduzzaman Rashu, Marina Ninkov, Christine M Wardell, et al.Plos Pathogens|December 16, 2021
A vesicular stomatitis virus-based prime-boost vaccination strategy induces potent and protective neutralizing antibodies against SARS-CoV-2Gyoung Nyoun Kim, Jung-Ah Choi, Kunyu Wu, et al.Plos Pathogens|November 29, 2022
Correction: A vesicular stomatitis virus-based prime-boost vaccination strategy induces potent and protective neutralizing antibodies against SARS-CoV-2Gyoung Nyoun Kim, Jung-Ah Choi, Kunyu Wu, et al.Pageof 3